Product Name: Human CD22 Antibody (Inotuzumab, Research Use)
Catalog Number: NBR-0012
Target Name: CD22
Trade Name: Inotuzumab
Antibody Drug Description: Inotuzumab ozogamicin, sold under the brand name Besponsa, is an antibody-drug conjugate medication used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD22
Synonyms: N/A
Target Description: Mediates B-cell B-cell interactions. May be involved in the localization of B-cells in lymphoid tissues. Binds sialylated glycoproteins; one of which is CD45.
Ensembl: ENSG00000012124
Uniprot: P20273